Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

590 Articles

Chris Lange | Feb 10, 2016 at 9:15 AM EST

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jan 28, 2016 at 8:40 AM EST

Short Sellers Become More Selective on Major Pharma

The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jan 13, 2016 at 9:15 AM EST

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks…

Chris Lange | Dec 28, 2015 at 9:35 AM EST

Major Pharma Short Interest Takes Another Giant Leap Forward

The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical…

Chris Lange | Dec 10, 2015 at 8:50 AM EST

Short Interest in Major Pharma Takes a Giant Leap

The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Jon C. Ogg | Dec 2, 2015 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: athenahealth, AT&T, Cepheid, Chevron, Dollar General, Mobileye and Many More

Wednesday's top analyst upgrades, downgrades and initiations include Athenhealth, AT&T, Cepheid, Chevron, Dollar General and Mobileye.

Chris Lange | Nov 11, 2015 at 8:15 AM EST

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical…

Chris Lange | Oct 27, 2015 at 9:05 AM EDT

Short Sellers Have Mixed Views on Major Pharma

The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Oct 12, 2015 at 9:25 AM EDT

Short Sellers Become More Selective on Major Pharma

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Oct 3, 2015 at 9:15 AM EDT

5 Big FDA Decisions Expected in October

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and…

Chris Lange | Sep 25, 2015 at 8:40 AM EDT

Short Sellers Boost Positions in Major Pharma

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Sep 11, 2015 at 8:25 AM EDT

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…

Chris Lange | Aug 26, 2015 at 8:05 AM EDT

Short Sellers Have Mixed Feelings on Major Pharma

The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Lee Jackson | Aug 18, 2015 at 8:22 AM EDT

4 Top Pharma Stocks That Should Outperform Out To 2016

ThinkstockWith a very nervous market, and the end of summer doldrums upon us, it may be time to look for…

Jon C. Ogg | Aug 12, 2015 at 5:14 PM EDT

Why the FDA Extended Review Date on Key Melanoma Drug Opdivo

Bristol-Myers Squibb announced that the FDA has now extended the action date for the supplemental biologics license application for Opdivo…

1 … 24 25 26 27 28 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Increase Bets in Major Pharma

Short Sellers Become More Selective on Major Pharma

Major Pharma Short Sellers Increase Bets

Major Pharma Short Interest Takes Another Giant Leap Forward

Short Interest in Major Pharma Takes a Giant Leap

Top Analyst Upgrades and Downgrades: athenahealth, AT&T, Cepheid, Chevron, Dollar General, Mobileye and Many More

Short Sellers Continue to Decrease Bets in Major Pharma

Short Sellers Have Mixed Views on Major Pharma

Short Sellers Become More Selective on Major Pharma

5 Big FDA Decisions Expected in October

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

Short Sellers Have Mixed Feelings on Major Pharma

4 Top Pharma Stocks That Should Outperform Out To 2016

Why the FDA Extended Review Date on Key Melanoma Drug Opdivo

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Increase Bets in Major Pharma

Short Sellers Become More Selective on Major Pharma

Major Pharma Short Sellers Increase Bets

Major Pharma Short Interest Takes Another Giant Leap Forward

Short Interest in Major Pharma Takes a Giant Leap

Top Analyst Upgrades and Downgrades: athenahealth, AT&T, Cepheid, Chevron, Dollar General, Mobileye and Many More

Short Sellers Continue to Decrease Bets in Major Pharma

Short Sellers Have Mixed Views on Major Pharma

Short Sellers Become More Selective on Major Pharma

5 Big FDA Decisions Expected in October

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

Short Sellers Have Mixed Feelings on Major Pharma

4 Top Pharma Stocks That Should Outperform Out To 2016

Why the FDA Extended Review Date on Key Melanoma Drug Opdivo

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

Featured Reads

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)